Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Moscinski

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 25, 2000
Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell lineX Hu, L C Moscinski, N I Valkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantationK K Fields, G J Elfenbein, W L Trudeau, et al.
Leukemia Research|August 26, 1998
Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed eventX Hu, L C Moscinski, B J Hill, et al.
Blood|April 1, 1994
High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myelomaO F Ballester, L C Moscinski, G H Lyman, et al.
Leukemia|May 4, 2007
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cellsT Lwin, L A Hazlehurst, Z Li, et al.
Cancer Research|August 17, 2001
An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanismX Hu, W E Janssen, L C Moscinski, et al.
Pediatric Research|August 1, 1986
Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitroL C Stork, D R Ambruso, S F Wallner, et al.
Leukemia|October 10, 2008
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosisT Lwin, L A Crespo, A Wu, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Urokinase plasminogen activator in ovarian cancerN C Gleeson, B J Hill, L C Moscinski, et al.
Current Topics in Microbiology and Immunology|January 1, 1996
Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at riskL L Garland, O F Ballester, F B Vasey, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 25, 2000
Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell lineX Hu, L C Moscinski, N I Valkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantationK K Fields, G J Elfenbein, W L Trudeau, et al.
Leukemia Research|August 26, 1998
Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed eventX Hu, L C Moscinski, B J Hill, et al.
Blood|April 1, 1994
High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myelomaO F Ballester, L C Moscinski, G H Lyman, et al.
Leukemia|May 4, 2007
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cellsT Lwin, L A Hazlehurst, Z Li, et al.
Cancer Research|August 17, 2001
An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanismX Hu, W E Janssen, L C Moscinski, et al.
Pediatric Research|August 1, 1986
Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitroL C Stork, D R Ambruso, S F Wallner, et al.
Leukemia|October 10, 2008
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosisT Lwin, L A Crespo, A Wu, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Urokinase plasminogen activator in ovarian cancerN C Gleeson, B J Hill, L C Moscinski, et al.
Current Topics in Microbiology and Immunology|January 1, 1996
Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at riskL L Garland, O F Ballester, F B Vasey, et al.
Pageof 5